经导管动脉栓塞治疗子宫肌瘤的临床分析  

Transcatheter Arterial Embolization in Treating Uterine Leiomyoma

作　　者：李翊[1] 李怀芳[1] 张弋[1] 王国良[2] 詹松华[2] 

机构地区：[1]同济大学附属同济医院妇产科,上海200065 [2]同济大学附属同济医院放射科,上海200065

出　　处：《同济大学学报（医学版）》2001年第5期45-47,共3页Journal of Tongji University(Medical Science)

摘　　要：目的　对经导管动脉栓塞治疗的子宫肌瘤患者的临床资料进行回顾性分析 ,以总结临床经验。方法　采用Seldinger’s插管方法作超选择子宫动脉栓塞 ,治疗 5 2例肌瘤患者 ,对其术前术后的临床资料进行分析。 结果　治疗后临床症状明显改善者占 84.6 % ,2 3例患者贫血明显改善 ,16例患者血红蛋白已达正常。观察 33例患者手术前后血液流变学改变 ,术后血液流变学增高者为 16例 ,P <0 .0 0 5。所有病例均无子宫坏死及严重并发症。结论　介入治疗用于子宫肌瘤患者是一种相对安全的治疗手段 ,但有一定的并发症 。Objective To summarize the clinical data of transcatheter arterial embolization treatment on uterine leiomyoma patients.Methods 52 leiomyoma patients were treated by Seldinger's superselective uterine transcatheter arterial embolization (TAE) and the clinical data before and after TAE were analyzed.Results No necrosis and serious complications were found. The clinical symptoms of 44 cases (84.6%) were improved significantly. The hemophthisis symptoms of 23 cases were also improved . The hemoglobin level of 16 cases had recovered.. Changes in hemorrheology before and after TAE of 16 cases out of 33 at random showed raising tendency significantly, P <0.005.Conclusion Interventional therapy is a relative safe treatment in uterine leiomyoma patients, but has complications, too, and the patients should be under close observation.

关 键 词：子宫肌瘤 经导管动脉栓塞术 介入放射学 TAE 

分 类 号：R737.33[医药卫生—肿瘤]